To screen or not to screen for subclinical hypothyroidism in pregnancy?

Hdl Handle:
http://hdl.handle.net/10147/294586
Title:
To screen or not to screen for subclinical hypothyroidism in pregnancy?
Authors:
Freyne, A; Byrne, B
Publisher:
Irish Medical Journal
Journal:
Irish Medical Journal
Issue Date:
Jun-2013
URI:
http://hdl.handle.net/10147/294586
Additional Links:
http://www.imj.ie/
Abstract:
Not unlike screening for gestational diabetes, controversy prevails over the value of screening for thyroid disease in pregnancy. Fortunately, overt hypothyroidism is rare in pregnancy (0.3-0.5%) because it is associated with infertility and increased rates of first trimester miscarriage. Studies suggest that obstetric complications such as hypertension, placental abruption, preterm delivery, perinatal morbidity and mortality are increased in women with hypothyroidism in pregnancy1 and there is evidence that the offspring of untreated mothers have neuropsychological and cognitive impairment. Subclinical hypothyroidism (Elevated TSH and normal Free T4) is estimated to be present in 2 â 2.5% of pregnant women. It is not as clearly associated with adverse obstetric and neonatal outcome but there is some evidence that maternal subclinical hypothyroidism is associated with impaired psychomotor development in the offspring 2.
Item Type:
Article
Language:
en
Keywords:
THYROID DISORDER; SCREENING; PREGNANCY

Full metadata record

DC FieldValue Language
dc.contributor.authorFreyne, Aen_GB
dc.contributor.authorByrne, Ben_GB
dc.date.accessioned2013-06-26T09:01:05Z-
dc.date.available2013-06-26T09:01:05Z-
dc.date.issued2013-06-
dc.identifier.urihttp://hdl.handle.net/10147/294586-
dc.description.abstractNot unlike screening for gestational diabetes, controversy prevails over the value of screening for thyroid disease in pregnancy. Fortunately, overt hypothyroidism is rare in pregnancy (0.3-0.5%) because it is associated with infertility and increased rates of first trimester miscarriage. Studies suggest that obstetric complications such as hypertension, placental abruption, preterm delivery, perinatal morbidity and mortality are increased in women with hypothyroidism in pregnancy1 and there is evidence that the offspring of untreated mothers have neuropsychological and cognitive impairment. Subclinical hypothyroidism (Elevated TSH and normal Free T4) is estimated to be present in 2 â 2.5% of pregnant women. It is not as clearly associated with adverse obstetric and neonatal outcome but there is some evidence that maternal subclinical hypothyroidism is associated with impaired psychomotor development in the offspring 2.en_GB
dc.language.isoenen
dc.publisherIrish Medical Journalen_GB
dc.relation.urlhttp://www.imj.ie/en_GB
dc.subjectTHYROID DISORDERen_GB
dc.subjectSCREENINGen_GB
dc.subjectPREGNANCYen_GB
dc.titleTo screen or not to screen for subclinical hypothyroidism in pregnancy?en_GB
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen_GB
dc.description.provinceLeinsteren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.